EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models

Hamid Khan, Hammad Riaz, Adeel Ahmed, Mubin Mustafa Kiyani, Sahibzada Muhammad Jawad, Syed Shahab Ud Din Shah, Turki Abualait, Fawaz Al-Hussain, Hong-Tao Li, Shahid Bashir

Regenerative Therapy · 2025-12 · 30 · 575-583

DOI: 10.1016/j.reth.2025.07.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2025-12. Verfasst von Hamid Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Salman Center for Disability Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Amyotrophic lateral sclerosis (ALS)CRISPR/Cas9Cas13Induced pluripotent cells (iPSCs)

Autor:innen und Institutionen

  • Department of Geriatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Institute of Brain Science and Brain-inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Shandong Institute of Brain Science and Brain-inspired Research, Jinan, 250117, China.
  • Molecular Biology and Bio Interfaces Engineering Lab, Department of Biological Sciences, Faculty of Sciences, International Islamic University Islamabad. H10, Islamabad, 44000, Pakistan.
  • Shifa College of Medical Technology, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • Department of Zoology, Islamia College University, Peshawar, Pakistan.

Förderung

  • King Salman Center for Disability Research

Zitieren

APA

Khan, H., Riaz, H., Ahmed, A., Kiyani, M. M., Jawad, S. M., Ud Din Shah, S. S., Abualait, T., Al-Hussain, F., Li, H. T., & Bashir, S. (2025). CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models. Regenerative Therapy, 30, 575-583. https://doi.org/10.1016/j.reth.2025.07.009

Vancouver

Khan H, Riaz H, Ahmed A, Kiyani MM, Jawad SM, Ud Din Shah SS, et al. CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models. Regenerative Therapy. 2025;30:575-583. doi:10.1016/j.reth.2025.07.009

BibTeX
@article{Khan2025,
  author = {Khan, Hamid and Riaz, Hammad and Ahmed, Adeel and Kiyani, Mubin Mustafa and Jawad, Sahibzada Muhammad and Ud Din Shah, Syed Shahab and Abualait, Turki and Al-Hussain, Fawaz and Li, Hong-Tao and Bashir, Shahid},
  title = {CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models},
  journal = {Regenerative Therapy},
  year = {2025},
  volume = {30},
  pages = {575--583},
  doi = {10.1016/j.reth.2025.07.009}
}
Kostenlos starten →